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ABSTRACT
Selenium is a vital micronutrient in many organisms. While traces are required for survival,
excess amounts are toxic; thus, selenium can be regarded as a biological “double-edged sword”.
Selenium is chemically similar to the essential element sulfur, but curiously, evolution has selected
the former over the latter for a subset of oxidoreductases. Enzymes involved in sulfur metabolism
are less discriminate in terms of preventing selenium incorporation; however, its specific
incorporation into selenoproteins reveals a highly discriminate process that is not completely
understood. In this work, we add knowledge to the mechanism for selenium-over-sulfur specificity
in hopes of further understanding the controlled regulation of selenium trafficking and the
prevention of its toxicity. We have identified SclA, a selenocysteine lyase in the nosocomial
pathogen, Enterococcus faecalis, and characterized its enzymatic activity and specificity for Lselenocysteine over L-cysteine. Human selenocysteine lyase contains a residue, D146, which plays
a significant role in determining its specificity. A D146K mutation eliminated this trait, allowing
non-specific L-cysteine degradation. Using computational biology, we identified an orthologous
residue in SclA, H100, and generated mutant enzymes with site-directed mutagenesis. The proteins
were overexpressed, purified, and characterized for their biochemical properties. All mutants
exhibited varying levels of activity towards L-selenocysteine, hinting at a catalytic role for H100.
Additionally, L-cysteine acted as a competitive inhibitor towards all enzymes with higher affinity
than L-selenocysteine. Finally, our experiments revealed that SclA possessed extremely poor
cysteine desulfurase activity with each mutation exhibiting subtle changes in turnover. Our
findings offer key insight into the molecular mechanisms behind selenium-over-sulfur specificity
and may further elucidate the role of selenocysteine lyases in vivo.
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CHAPTER 1: INTRODUCTION
Selenium and its Role in Biology
Selenium is an important trace element found in all known domains of life. In many
organisms, selenium functions as an essential micronutrient when present in small amounts, but in
excess, the reactive nonmetal becomes highly toxic and therefore must be kept under tight
regulation—this phenomenon is why selenium is often regarded as a “double-edged sword” in
biology. Selenium shares many properties with the nonmetal, sulfur, as both elements are part of
the chalcogens group on the periodic table. While both elements are similar in terms of atomic
character and involvement in redox reactions, sulfur is much more abundant in nature as a
macronutrient compared to the uncommon selenium.
The most well-characterized biological form of selenium is selenocysteine, the 21st amino
acid [1, 2]. Unlike the standard twenty proteinogenic amino acids, selenocysteine is genetically
encoded by the UGA stop codon; specifically, a stem loop structure termed the SECIS element
(selenocysteine insertion sequence) and tRNASec reprogram the codon for selenocysteine insertion
into the nascent polypeptide rather than premature termination of translation [3, 4]. In bacteria,
this process is mediated by the following gene products: SelA, SelB, selC, and SelD [2, 5, 6].
Interestingly, selenocysteine possesses chemical attributes that are not present in its sulfur analog,
cysteine. First, the selenol group of selenocysteine has a pKa of ~5.2 while the thiol group of
cysteine has a pKa of ~8.5; because of this, at physiological pH, free selenocysteine is extremely
reactive as a result of its deprotonated side chain while cysteine’s protonated side chain renders it
less reactive in comparison [7]. Second, selenocysteine can resist over-oxidation in some redoxdependent enzymes such as thioredoxin reductase while cysteine usually cannot recover from such
1

a destructive event [8]. Lastly, the presence of a selenocysteine residue in the active sites of redoxactive enzymes generally confers a catalytic advantage compared to their cysteine-containing
homologs and mutants [9-11]. These subtle properties regarding selenium can be seen as
evolutionary favorable in the context of some biological systems.

Biological Incorporation of Selenium
While the aforementioned redox advantages of selenium imply a vast difference between
it and sulfur, biology often has a difficult time distinguishing between the two atoms. In most cases
when cells contain a high selenium-to-sulfur ratio, selenium is misincorporated into biomolecules
in place of sulfur based on the lack of specificity of key sulfur metabolic enzymes which are nondiscriminate and fail to prevent the insertion of selenium into these molecules—this mechanism is
still not completely understood [12]. In bacteria, these key enzymes are O-acetylserine
sulfhydrylase (CysK) and cysteinyl-tRNA synthetase (CysRS); CysK respectively generates
cysteine and selenocysteine using sulfide (HS-) and selenide (HSe-), while CysRS can mischarge
tRNACys with selenocysteine instead of cysteine [12, 13]. Therefore, via the non-specific
incorporation pathway, the cysteines and methionines of proteins are inadvertently replaced by
selenocysteines and selenomethionines, respectively [12, 14-18]. It is important to note that the
misincorporation of sulfur in place of selenium has not been observed in vivo, heavily implying
that the enzymes involved in selenium metabolism are much stricter than their sulfur metabolic
counterparts in the discrimination of the two chalcogens. In an environment where cells contain a
high sulfur-to-selenium ratio, a specific incorporation pathway dominates where selenium is
purposefully inserted into biomolecules in three different ways. First, as previously stated,
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selenium can be specifically incorporated as selenocysteine into proteins (called selenoproteins)
through a recoded stop codon; as mentioned earlier, the reactivity of selenocysteine greatly
influences the catalytic properties of selenoproteins. Second, selenium can also be incorporated
into the wobble position of some tRNAs as 2-selenouridine, but the role of this modification is
poorly understood [19-21]. Finally, selenium can be incorporated as a labile cofactor into the active
sites of certain molybdenum hydroxylases, often playing a role in enzyme catalysis [22-25]. Since
many organisms require selenium for life, it seems logical that the specific incorporation pathway
functions to provide the trace element to fill that critical need in the presence of immense amounts
of sulfur.
The specific incorporation of selenium requires the presence of an enzyme called
selenophosphate synthetase (SPS); in bacteria, SPS is the gene product of selD [26]. The product
of SPS is selenophosphate (SePO3), a molecule with high group transfer potential which functions
as a biochemical currency similar to adenosine triphosphate (ATP) by donating selenium to the
specific incorporation pathways [27]. Because SePO3 is rarely present in the cytoplasm, SPS must
generate it via an ATP-dependent process using its preferred substrate: HSe- [26]. Although a
precursor to SePO3, HSe- is highly reactive and likely very toxic to the cell, often redox cycling
with intracellular thiols and rapidly generating reactive oxygen species such as superoxide [28,
29]. Nevertheless, if HSe- is required for the production of SePO3 and ultimately the biosynthesis
of selenium-containing biomolecules, then it must be generated in a controlled manner. One way
this occurs is through the biochemical discrimination of selenium and sulfur. For example, in
Escherichia coli, SPS exhibits a type of substrate specificity where it only recognizes HSe- and
produces SePO3; the enzyme does not generate thiophosphate (SPO3) from HS- [30]. This concept
3

in selenium biochemistry is poorly understood especially considering how the cellular
concentration of HSe- pales in comparison to the substantial amount of HS- in the cytosol—the
ability for an enzyme to recognize a selenium atom amongst an enormous pool of sulfur would
most likely require a sophisticated mechanism. Coincidentally, the best candidates to study this
mechanism are enzymes from the NifS-like protein family for which a small subset is involved in
selenium-over-sulfur discrimination.

The NifS-like Protein Family
NifS-like proteins are pyridoxal 5’-phosphate (PLP)-dependent aminotransferases,
homologous to the nifS (nitrogen fixation) gene product in Azotobacter vinelandii: NifS [31]. This
enzyme functions as a cysteine desulfurase (CDS) where it degrades L-cysteine into L-alanine and
HS- [31, 32]. After L-cysteine degradation, the sulfur atom is covalently bound to the catalytic
thiolate of the CDS through a persulfide intermediate; with the help of an array of scaffolding
proteins, the inorganic sulfur is subsequently mobilized to important biomolecules such as ironsulfur (Fe-S) cluster-containing proteins, thiamine, and molybdenum cofactor, demonstrating a
clear role for CDSs in vivo [32]. The majority of knowledge stems from analyses on the known
CDSs in E. coli: IscS, CSD (CsdA), and SufS (CsdB). While the three enzymes recognize Lcysteine as their primary substrate, they also nonspecifically act on L-selenocysteine with varying
degrees of activity [32-36]. On the other hand, a subset of NifS-like enzymes acts specifically on
L-selenocysteine with no regard to the L-cysteine pool within the cell, thus exhibiting
selenocysteine lyase (SCL) activity and therefore degrading L-selenocysteine into L-alanine and
HSe- [37, 38]. Moreover, SCLs are curiously inhibited by L-cysteine in either a competitive or
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non-competitive manner, depending on the enzyme [37-39]. Because SCLs generate HSe-, it is
possible that they may be involved in channeling selenium into the specific incorporation pathway,
analogous to how CDSs mobilize sulfur to certain biomolecules—this may be primarily mediated
by its selenium-over-sulfur discriminatory ability. Unfortunately, this is speculative without clear
evidence of the exact mechanism by which this occurs, and because the knowledge on SCLs is so
scarce, their role in vivo has not yet been identified. The lack of information rises from the fact
that most of the SCLs that have been biochemically characterized are from mammals where
selenium metabolism is not as understood as it is in prokaryotes [37, 39, 40]. In bacteria, several
SCLs were reported to have been found, but only one of them was purified and characterized from
the crude lysate of Citrobacter freundii [38, 41]. Indeed, characterizing putative SCLs that are
already identified in selenium-utilizing organisms would help us gain more knowledge on their
biological function.

A Selenocysteine Lyase in Enterococcus faecalis
While studying the selenium metabolism of several pathogens, our lab identified a NifSlike protein in Enterococcus faecalis [42]. E. faecalis is a multidrug-resistant pathogen and a
prominent nosocomial responsible for endocarditis, bacteremia, and urinary tract infections [43].
Aside from these diseases, its alarming ability to effortlessly form biofilms on the surfaces of
medical devices such as catheters and pacemakers makes it an ongoing healthcare issue [44].
Curiously, E. faecalis has been identified as an organism that harbors an “orphan selD” in the sense
that it does not contain the genes necessary to synthesize selenoproteins or selenium-containing
tRNAs but instead may utilize SePO3 for some other unknown trait [42, 45]. Additionally, genes
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that are putatively involved with the biosynthesis of a selenium-dependent molybdenum
hydroxylase (SDMH) were identified in the same genetic locus as selD [42, 46].
We have previously demonstrated that the SDMH in question is a xanthine dehydrogenase
(XDH) that has been shown to significantly increase biofilm formation in the presence of uric acid,
molybdate, and selenite [47]. In the same genetic locus, many uncharacterized genes were
annotated to be hypothetically involved in selenium metabolism—one of which is EF2568, whose
gene product encodes a putative NifS-like protein [42]. We have previously shown through cloning
and biochemical characterization that the gene product of EF2568 is an SCL due to its specificity
for L-selenocysteine over L-cysteine [48]. Based on our initial characterization of the protein and
the fact that it may be involved in selenium trafficking according to the gene’s location amongst
other selenium-related genes, we hereby propose a renaming of the open reading frame to sclA
(selenocysteine lyase). Its true role in vivo, however, is still unclear, and the mechanism by which
it specifically recognizes selenium is unknown.

The Mechanism for Selenium-over-Sulfur Specificity
In NifS-like enzymes, the catalytic mechanism for cysteine degradation follows a general
two-step procedure. First, the substrate (L-cysteine) binds to PLP in the active site, forming an
external aldimine linkage; afterwards, the thiolate ion of the core catalytic cysteine residue
nucleophilically attacks the chalcogen atom of the substrate-PLP complex, yielding a sulfur atom
bound to the cysteine residue via a persulfide linkage and producing free L-alanine [49]. The
ionization state of the cysteine residue’s side chain is key to the catalysis, but it may also play a
role in discriminating between sulfur and selenium. In CDSs, the deprotonated thiolate anion is
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dominant, acting as a nucleophile to non-specifically attack the sulfur of L-cysteine or the selenium
of L-selenocysteine. In SCLs, however, it is believed that the protonated thiol group is preferred
in order to offer specificity towards L-selenocysteine. Because the protonated thiol is mostly
unreactive and does not act as a potent nucleophile compared to the thiolate, it is unclear how the
reaction would proceed in general.
A recent investigation into the selenium-over-sulfur specificity mechanism of human SCL
(hSCL) has shed some light on this topic. By using a site-directed mutagenesis approach on hSCL,
the authors found that mutation of the aspartic acid at amino acid position 146 (D146) to a lysine
(D146K) resulted in novel activity towards L-cysteine that had been previously absent [50, 51]. In
other words, the enzyme became non-discriminate and effectively switched from an SCL to a CDS
with a single point mutation. This seems to imply that D146 is either the sole determinant of
selenium specificity or at least plays a significant role in the mechanism. Specifically, the authors
proposed that, while a protonated thiol could not react with the thiol of L-cysteine, the nucleophilic
selenolate anion of L-selenocysteine may deprotonate the cysteine residue’s thiol which could then
attack the electrophilic selenol group, causing the reaction to proceed with high specificity for
selenium [51]. In this case, it is believed that the nearby carboxylate anion of D146 serves to
increase the pKa of C388 (the catalytic cysteine) through a like-charge destabilization of its thiolate
anion; thus, the protonated thiol form would dominate, allowing only reaction with Lselenocysteine. When D146 was mutated to a lysine, the charge was inverted and may have
reduced the pKa of C388. It is possible that the lysyl side chain’s amino cation stabilized the
deprotonated thiolate species, allowing C388 to react with both substrates. Overall, this implies
that the presence of D146 heavily influences the pKa of C388 and may prevent the residue from
7

achieving the thiolate form present in other NifS-like enzymes. It should be noted, however, that
the pKa of the active site cysteine was not determined in this study.
Because D146K of hSCL was reported to eliminate L-selenocysteine specificity, we
wondered if an orthologous residue in SclA shared a similar role in influencing the pKa of its
catalytic cysteine. Aligning the primary sequence of hSCL to SclA revealed a histidine at amino
acid position 100 (H100) in SclA that directly aligns to D146, implying that the former may also
function as a determinant of selenium-over-sulfur specificity [48]. In this work, we set out to
determine the function of H100 through a site-directed mutagenesis approach based on the
previous work on hSCL. We hope that the results of this work further add knowledge to the
mechanism of selenium-over-sulfur discrimination and give insight as to how SCLs play a role in
trafficking selenium and preventing toxicity.

8

CHAPTER 2: MATERIALS AND METHODS
Materials
Oligonucleotides were purchased from Integrated DNA Technologies. T4 DNA ligase, T4
DNA ligase reaction buffer, T4 Polynucleotide Kinase (PNK), Q5 High-Fidelity DNA Polymerase
(Q5), Q5 reaction buffer, Q5 High GC Enhancer, Deoxynucleotide (dNTP) Solution Mix, and
DpnI were all purchased from New England Biolabs. E. coli strains NEB 5-α and Lemo21(DE3)
were purchased from New England Biolabs. Gel Loading Dye Blue (6×) and TriDye 1 kb DNA
Ladder were purchased from New England Biolabs. Pierce Universal Nuclease for Cell Lysis and
HisPur Cobalt Resin were purchased from Thermo Fisher Scientific. Spectra Multicolor Broad
Range Protein Ladder was purchased from Thermo Fisher Scientific. The French Press and the
Manual-Fill 40K Cell (FA-032) were purchased from Glen-Mills. Bio-Rad Protein Assay Dye
Reagent Concentrate (Bradford reagent) was purchased from Bio-Rad. Q Sepharose Fast Flow was
purchased from GE Healthcare. L-Selenocystine was purchased from Acros Organics. L-Cysteine
hydrochloride monohydrate was purchased from Alfa Aesar.

Growth Media and Bacterial Maintenance
All E. coli strains were maintained with lysogeny broth (LB) as per the Lennox formulation
(1.0% tryptone, 0.5% yeast extract, 0.5% NaCl) [52-54]. For solid media, LB was supplemented
with 1.5% agar. Unless stated otherwise, E. coli strains used specifically for protein expression
were maintained using LB supplemented with 2 KOH pellets per liter, 0.2% glucose, 0.2%
glycerol, and 200 μg/mL ampicillin—this medium is referred to as “modified LB” in this work.
Modified LB supplemented with 1.5% agar was used to maintain these strains on solid media. For
9

overnight starter cultures, modified LB was supplemented with 1 mM MgSO4. For overexpression
cultures, modified LB was supplemented with 1 mM MgSO4 and 0.1 mM pyridoxine, but glucose
was omitted entirely. For starter cultures and smaller volumes, the Barnstead MaxQ 4000 orbital
shaker was used. For overexpression cultures and larger volumes, the New Brunswick Innova 4230
shaker was used. All agitation steps were carried out at 240 rpm.

Sequence Alignments and Homology Modeling
FASTA sequences of various characterized NifS-like enzymes were selected and aligned
using Clustal Omega [55]. These sequences were obtained from the following UniProt IDs:
Q96I15 (hSCL), Q831E3 (E. faecalis SclA), O32164 (Bacillus subtilis SufS), P77444 (E. coli
SufS/CsdB), Q46925 (E. coli CSD/CsdA), P0A6B7 (E. coli IscS), and P05341 (A. vinelandii
NifS). The sequences were ordered by input as shown in Figure 1.
To create 3-D structures of hSCL and SclA for active site analysis, the following methods
were used. The Protein Data Bank (PDB) ID of hSCL, 3GZC, was used to generate a 3-D structure
using PyMOL [56]. Because no crystal structure of SclA existed at the time of this writing, it had
to be modeled in a different manner. The aforementioned FASTA sequence of SclA was used to
find templates of closest putative structural homology using ExPASy’s SWISS-MODEL [57]. The
SclA sequence was then threaded through the top result, B. subtilis SufS (PDB ID: 5J8Q), to
generate a hypothetical structural model. The data for this homology model were converted to a
PDB format and then used to generate a 3-D structure using PyMOL. D146K and H100 mutants
were also modeled with the same software.

10

Site-directed Mutagenesis
The pET100 vector designated as pRT1 containing sclA (EF2568) cloned from E. faecalis
V583 was subjected to ‘Round-the-horn site-directed mutagenesis [58, 59]. Briefly, primers were
designed with the intent to mutate the histidine at amino acid position 100 to the following
residues: lysine (H100K), aspartate (H100D), alanine (H100A), and asparagine (H100N). Forward
primers contained the mutated codons on the 5’ ends while the reverse primer was designed to
bind directly next to the site of mutation. All primers were designed to have a melting temperature
of ~60 °C and are referenced in Table 1. Primers were phosphorylated by incubating a 50 μL
mixture containing 1× T4 DNA ligase reaction buffer, 10 μM primers, and 1 μL of PNK (10,000
U/mL) at 37 °C for 1 hour; afterwards, the PNK was inactivated with a final 5-minute incubation
at 95 °C. For each point mutant, several 50 μL master mixes of the following reagents were
prepared on ice: 1× Q5 reaction buffer, 1× Q5 High GC Enhancer, 300 nM forward and reverse
primers, 0.2 mM dNTPs, 0.5 ng of pRT1, and 0.5 μL of Q5 (2,000 U/mL). To perform the
polymerase chain reaction (PCR), the master mixes were placed in a Techne TC-312 thermal
cycler with a pre-heated lid and were initially denatured at 98 °C for 1 minute. Afterwards, the
following program was cycled through 27 times: denaturation at 96 °C for 30 seconds, annealing
at 64 °C for 30 seconds, and extension at 72 °C for 14 minutes. Finally, samples were cooled at 18
°C for 1 minute. To check for PCR products, 5 μL samples were mixed with 2 μL of Gel Loading
Dye Blue (6×). From these samples, 5 μL along with 5 μL of TriDye 1 kb DNA Ladder were
loaded on a 1% agarose gel prepared with 1× Tris-acetate-EDTA (TAE, 40 mM
tris(hydroxymethyl)aminomethane [Tris], 20 mM acetate, 10 mM ethylenediaminetetraacetate
[EDTA]) and 0.5 μg/mL ethidium bromide and were electrophoresed at 100 V for 30 minutes.
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Gel Extraction and Ligation
After mutagenesis, samples were treated with 1 μL of DpnI (20,000 U/mL) and incubated
at 37 °C for 1 hour to digest the template plasmid. Digested samples were electrophoresed on a
1% agarose gel prepared with 1× TAE and 0.005% crystal violet at 100 V for 30 minutes. The
target bands were excised with a sterile razor blade, transferred to 1.7 mL microcentrifuge tubes
containing 500 μL of gel melting buffer (5.5 M guanidinium thiocyanate, 0.1 M sodium acetate,
[pH 5.0]), and melted in a Fisher Isotemp 210 water bath at 50 °C for 10 minutes. After samples
were fully dissolved and denatured, 150 μL of 100% isopropanol were added to each tube and
vortexed thoroughly. Unless otherwise stated, all centrifugation steps regarding spin columns for
the rest of this work were carried out using an Eppendorf 5418 centrifuge. Denatured samples were
bound to DNA Mini-Spin Columns (Enzymax LLC) and centrifuged twice at 2,000 × g for 1
minute to discard the non-bound flow-through. An additional 300 μL of gel melting buffer were
added to each sample, and each tube was centrifuged at 2,000 × g for 1 minute. Samples were
washed with a column wash buffer (5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonate-KOH
[HEPES-KOH], 20 mM NaCl, 0.02 mM EDTA, 80% ethanol, [pH 8.3]) three times at decreasing
volumes per wash: 400 μL for the first wash, 250 μL for the second wash, and 50 μL for the final
wash—all samples were centrifuged at 2,000 × g for 1 minute for every subsequent wash to remove
the buffer. Afterwards, the samples were centrifuged at 16,900 × g for 1 minute to remove any
residual ethanol. Finally, 50 μL of column elution buffer (2.5 mM Tris-HCl, 0.1 mM EDTA, [pH
8.0]) were transferred to the center of each column; purified products were allowed to incubate at
room temperature for 1 minute before finally being eluted by centrifugation at 16,900 × g for 1
minute.
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Purified products were ligated by incubating a 10 μL mixture containing 1× T4 DNA ligase
reaction buffer, 8 μL of PCR product, and 0.4 μL of T4 DNA Ligase (400,000 U/mL) at room
temperature for 10 minutes. After ligation, mutant plasmids were transformed into E. coli strain
NEB 5-α. Briefly, NEB 5-α was streaked onto an LB plate and incubated overnight at 37 °C. A
single colony was selected and used to inoculate a 1 mL starter culture composed of LB and 0.2%
glucose which aerobically grew overnight at 37 °C. Starter cultures were diluted 1:100 into several
1 mL broths containing LB and 0.2% glucose and allowed to grow for 2 hours at 37 °C. After
reaching mid-exponential phase, cultures were harvested at 5,000 × g for 3 minutes. After
discarding media, pellets were resuspended in 100 μL Transformation and Storage Solution (TSS,
10% polyethylene glycol 8000, 30 mM MgCl2, 5% dimethyl sulfoxide, 0.2% glucose, dissolved
in LB), and 40 μL of resuspended cells were transferred to pre-chilled 1.7 mL microcentrifuge
tubes [60]. Five microliters of each ligated PCR product were transferred to their respective 40 μL
mixtures to begin transformation. Competent cells were incubated on ice for 10 minutes, at room
temperature for 10 minutes, and finally on ice again for an additional 10 minutes to allow for
transformation of ligated products. One milliliter of LB with 0.2% glucose was added to each
transformant tube, and all tubes were incubated at 37 °C for 1 hour to allow for cell recovery.
Recovered cells were harvested at 5,000 × g for 3 minutes, and ~900 μL of supernatant were
discarded. Pellets were resuspended with the remaining ~100 μL of supernatant and transferred to
LB agar plates supplemented with 100 μg/mL ampicillin. Plates were incubated overnight at 37
°C.
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Plasmid Preparation and Sequencing
Several transformant colonies were selected for minipreps via inoculation of several 2 mL
LB broths which were cultured overnight at 37 °C. Cells from each overnight culture were
harvested at 7,000 × g for 5 minutes, resuspended with 200 μL of cell resuspension buffer (50 mM
Tris-HCl, 10 mM EDTA, 50 μg/mL RNase A, [pH 8.0]), and vortexed thoroughly to remove cell
clumps. Afterwards, 250 μL of cell lysis solution (0.2 M NaOH, 1% sodium dodecyl sulfate) were
added to resuspended cells, and the mixture was inverted several times and incubated at room
temperature for 5 minutes to allow for cell lysis. To begin removing genomic DNA and protein,
350 μL of neutralization buffer (4 M guanidinium-HCl, 0.5 M potassium acetate, [pH 4.2]) were
added to each lysate; all lysates were inverted several times before being centrifuged at 16,900 ×
g for 10 minutes. The supernatants were transferred to DNA Mini-Spin Columns and centrifuged
twice at 2,000 × g for 1 minute to bind the target plasmids. Columns were washed with 300 μL of
guanidine wash buffer (5 M guanidinium-HCl, 20 mM Bis-Tris-HCl, 33% ethanol, [pH 6.5]) and
centrifuged at 2,000 × g for 1 minute. As described earlier, samples were additionally washed with
column wash buffer three times at decreasing volumes per wash: 400 μL for the first wash, 225
μL for the second wash, and 75 μL for the final wash—all samples were centrifuged at 2,000 × g
for 1 minute for every subsequent wash to remove the buffer. Samples were centrifuged at 16,900
× g for 1 minute to remove all traces of ethanol. Finally, as described earlier, 50 μL of column
elution buffer were added to the center of each spin column—samples incubated at room
temperature for 1 minute before being centrifuged at 16,900 × g for 1 minute to elute the purified
samples.
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Mutations were confirmed by Sanger sequencing provided by GENEWIZ—
chromatograms were generated using the sequencing data and visibly inspected using SnapGene
Viewer (GSL Biotech). Upon confirmation of each mutation, all plasmids were transformed into
E. coli strain Lemo21(DE3). Briefly, Lemo21(DE3) was streaked onto an LB plate supplemented
with 34 μg/mL chloramphenicol and incubated overnight at 37 °C. A single colony was used to
inoculate a 1 mL starter culture containing LB supplemented with 0.2% glucose and 34 μg/mL
chloramphenicol which was allowed to aerobically incubate overnight at 37 °C. The starter culture
was diluted 1:100 into several 1 mL broths containing identical media and grew for 2 hours at 37
°C. The TSS method as described earlier was used to transform the plasmids into Lemo21(DE3).
After cell recovery and harvesting, 100 μL of competent cells were plated on LB agar
supplemented with 100 μg/mL ampicillin and 34 μg/mL chloramphenicol and incubated overnight
at 37 °C. Single transformant colonies were used to make 15% glycerol stocks which were stored
at -80 °C.

Expression and Purification of SclA Mutants
Wild-type (WT) SclA and mutants were overexpressed in E. coli strain Lemo21(DE3) and
purified using N-terminal His6-tags. Unless stated otherwise, the following procedure was used for
overexpression and purification of WT and all mutants mentioned in this study. Glycerol stocks of
these strains were streaked onto modified LB agar and incubated overnight at 37 °C. Pure colonies
were used to inoculate 50 mL starter cultures which were allowed to shake overnight at 37 °C.
Starter cultures were diluted 1:100 into 4 liter (2 × 2 liter) overexpression cultures which were
allowed to grow for 1.5 hours at 37 °C. The temperature was then immediately shifted to 25 °C
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and allowed to equilibrate for an additional 20 minutes. After equilibration, the cultures were
induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for 7 hours. Cultures were
immediately placed on ice, transferred to pre-chilled 1-liter centrifuge bottles, and harvested at
12,000 × g for 10 minutes at 4 °C using a Sorvall RC6+ centrifuge—this device was used for all
harvest and clarification steps unless otherwise stated. Cell pellets were resuspended with 25 mL
of cold cell wash buffer (25 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, [pH 8.0]), harvested as
stated before, and stored at -80 °C.
Before lysis, cells were thawed at 4 °C, resuspended in 80 mL of cold lysis buffer (25 mM
Tris-HCl, 300 mM NaCl, 0.05% Tween-20, 5% glycerol, [pH 8.0]) supplemented with 1 mM
benzamidine, and vortexed for 1 minute. One microliter of Pierce Universal Nuclease for Cell
Lysis (250 U/μL) was added to the diluted suspension to digest any remaining nucleic acids. The
suspension was passed through a French Press with a pre-chilled Manual-Fill 40K Cell three times
at maximum standard pressure (40,000 psi) to completely lyse the cells. All centrifugation and
purification steps were carried out at 4 °C. The crude lysate was clarified at 28,900 × g for 20
minutes. From this point onward, all centrifugation steps regarding resin harvest were carried out
using a Hermle Z400K centrifuge. Two milliliters of HisPur Cobalt Resin were washed with 20
mL of cobalt binding buffer (25 mM Tris-HCl, 300 mM NaCl, 5 mM imidazole, 0.05% Tween20, 14 mM β-mercaptoethanol [β-Me], 5% glycerol, [pH 8.0]) and centrifuged at 1,000 × g for 5
minutes. After decanting the supernatant, the washed resin was mixed with the soluble lysate in a
50 mL conical tube and allowed to batch-bind via end over end rotation for 1 hour at 4 °C. The
mixture was centrifuged at 1,000 × g for 5 minutes to collect the protein-bound resin. From here
on out, the Bradford assay was utilized to track the protein across the purification by sampling 5
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μL from each step and adding to 100 μL of 1× Bradford reagent in a 96-well plate [61]. Resin was
resuspended with cobalt binding buffer, transferred to a gravity column, and pre-washed with
cobalt wash buffer (25 mM Tris-HCl, 300 mM NaCl, 20 mM imidazole, 0.05% Tween-20, 14 mM
β-Me, 5% glycerol, [pH 8.0]) at 75% of the bed volume. Afterwards, the resin was washed with 6
bed volumes of cobalt wash buffer at least 4 times. To dilute the wash buffer, the resin was then
pre-eluted with cobalt elution buffer (25 mM Tris-HCl, 300 mM NaCl, 250 mM imidazole, 0.05%
Tween-20, 14 mM β-Me, 5% glycerol, [pH 8.0]) at 75% of the bed volume. Afterwards, the target
protein was eluted with 2 bed volumes of cobalt elution buffer at least 4 times. Once cobalt affinity
was completed, 1 mL of Q Sepharose Fast Flow resin was washed with 20 mL of Q binding buffer
(12.5 mM Tris-HCl, 50 mM NaCl, 0.05% Tween-20, 14 mM β-Me, 5% glycerol, 0.1 mM EDTA,
[pH 8.0]). Elutions were pooled together and mixed with Q resin; to dilute the imidazole, the total
volume of the binding mixture was brought up to 40 mL with deionized water (dH2O). Protein was
allowed to bind for 15 minutes in the cold as described earlier. Protein-bound resin was harvested
via centrifugation at 1,000 × g for 5 minutes. Resin was resuspended with Q binding buffer,
transferred to a gravity column, and pre-washed with Q wash buffer (12.5 mM Tris-HCl, 100 mM
NaCl, 0.05% Tween-20, 14 mM β-Me, 5% glycerol, 0.1 mM EDTA, [pH 8.0]) at 75% of the bed
volume. Two bed volumes of Q wash buffer were used to wash the resin at least 2 times. To dilute
the wash buffer, the resin was pre-eluted with Q elution buffer (12.5 mM Tris-HCl, 500 mM NaCl,
0.05% Tween-20, 14 mM β-Me, 5% glycerol, 0.1 mM EDTA, [pH 8.0]) at 75% of the bed volume.
Afterwards, protein was eluted with 1 bed volume of Q elution buffer at least 6 times. Elutions
were pooled together and dialyzed against 1 liter of storage buffer (50 mM HEPES-KOH, 5%
glycerol, [pH 7.5]) overnight at 4 °C.
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Protein Analysis and Quantification
Induction and purification of all proteins were analyzed via sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) [62]. To assess the induction of each protein, 1
mL samples of the overexpression cultures were taken before and after full protein induction. The
sample before addition of IPTG was labeled “pre-IPTG” while the sample after full induction was
labeled “post-IPTG”. The optical densities at 600 nm (OD600) of each sample were analyzed using
an Agilent 8453 UV-visible spectrophotometer. The OD600 of the post-IPTG sample was
normalized to the OD600 of the pre-IPTG sample. Both samples were harvested at 12,000 × g for
5 minutes using an Eppendorf 5418 centrifuge. After decanting media, pellets were stored at -80
°C. For sample preparation of induction pellets, 40 μL of 2× Laemmli sample buffer were used to
resuspend the cells before lysing via incubation at 100 °C in a sand bath for 5 minutes. For general
sample preparation, 8 μL were pulled from all steps of the purification scheme, mixed with 32 μL
of 2× Laemmli sample buffer, and heated similarly for 5 minutes. Five microliters of boiled
samples were routinely loaded on 12% Tris-glycine gels and electrophoresed at 35 mA for 1 hour.
Gels were gently washed with dH2O for 5 minutes before replacing the water with a gel staining
solution (0.02% Coomassie Brilliant Blue G-250, 10% methanol, 10% acetate) and microwaving
until the staining solution began to boil. After initial staining, gels were agitated on a low-speed
orbital shaker for 10 minutes before replacing staining solution with 10% acetate for destaining.
To accelerate the destaining process, the solution was microwaved to a boil, then Kimwipes were
added while the gels were allowed to agitate as before. Gels with clear backgrounds were deemed
ready for imaging. Destained gels were gently washed with dH2O before being analyzed with a
ChemiDoc MP Imaging System.
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Protein concentrations of dialyzed enzymes were quantified via their absorbance profiles
at 280 nm. Briefly, samples were diluted 1:10 in 6 M guanidinium-HCl and read using an Agilent
8453 UV-visible spectrophotometer. The predicted molecular weight and theoretical molar
absorptivity coefficient of SclA at 280 nm were 41,525.86 Da and 39,420 M-1 cm-1 respectively,
as determined by the ProtParam tool by ExPASy [63]. Beer’s law was used to calculate protein
concentration [64]. Proteins were stored in 400 μL aliquots at -20 °C.

Lead Acetate Assay
The SCL activities of all purified proteins were analyzed with the lead acetate assay [37].
Upon addition of lead acetate, any hydrogen selenide (H2Se) present reacts to form lead selenide
(PbSe) which can be detected at 400 nm. The assay was carried out in a 96-well plate format. The
assay mixture was formulated containing the following reagents: 50 mM HEPES-KOH (pH 7.5),
5 mM dithiothreitol (DTT), 0.2 mM PLP, 1 mM pyruvate, and 0.02 mM EDTA. The substrate was
prepared by first dissolving the oxidized form, L-selenocystine, with NaOH at a 1:1 molar ratio of
L-selenocysteine-to-NaOH—the diselenide molecule is automatically reduced by DTT to Lselenocysteine in the assay. An enzyme mixture was prepared containing 0.3 mg/mL SclA and 0.8
mg/mL bovine serum albumin (BSA); from this mix, 5 μL were added to 90 μL of 1× assay
mixture. To begin the enzymatic reaction, 5 μL of L-selenocystine were added to the above mixture
for a final volume of 100 μL. The assay was carried out in triplicate at 25 °C for various lengths
of time to ascertain the initial rates of HSe- production at varying substrate concentrations. Enzyme
was omitted in a blank as a negative control. Reactions were quenched with 100 μL of 5 mM lead
acetate dissolved in 0.5 M HCl. The optical densities at 400 nm of 200 μL quenched samples were
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analyzed with a SpectraMax 190 Microplate Reader. The molar turbidity coefficient of PbSe at
400 nm is 1.18 × 104 M-1 cm-1 and was used to calculate the HSe- concentration via Beer’s law [35,
64]. Blank rates were averaged and subtracted from sample rates. Rates were fit to the MichaelisMenten equation using GraphPad Prism 8. For inhibition studies, several solutions of 1× assay
mixture were supplemented with 0.25 mM, 0.5 mM, 0.75 mM, and 1 mM L-cysteine. For
inhibition assays, rates were transformed to generate double-reciprocal plots; after inspection of
the trendlines in these plots, rates were fit to a competitive inhibition model using GraphPad Prism
8. All kinetic parameters and standard deviations were calculated using GraphPad Prism 8.

Methylene Blue Assay
The CDS activities of all purified proteins were analyzed with the methylene blue assay
[65]. Upon addition of N,N-dimethyl-p-phenylenediamine (DPD) and FeCl3, any hydrogen sulfide
(H2S) present reacts to form methylene blue which can be detected at 650 nm. The assay was
carried out in a 96-well plate format. The assay mixture was formulated containing the following
reagents: 50 mM HEPES-KOH (pH 7.5), 5 mM DTT, 0.2 mM PLP, 1 mM pyruvate, and 0.02 mM
EDTA. Two enzyme mixtures supplemented with 0.16 mg/mL BSA were prepared containing
0.06 mg/mL SclA and 0.4 mg/mL SclA; from these mixes, 25 μL were added to 50 μL of 2× assay
mixture. To begin the enzymatic reaction, 25 μL of 1 mM L-cysteine were added to the above
mixture for a final volume of 100 μL. The assay was carried out in triplicate at 25 °C for various
lengths of time to determine HS- production. Enzyme was omitted in a blank as a negative control.
Reactions were quenched with 10 μL of 20 mM DPD dissolved in 7.2 M HCl and 10 μL of 30 mM
FeCl3 dissolved in 1.2 M HCl. Samples were allowed to incubate at 25 °C for 10 minutes for color
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development. The absorbances at 650 nm of 120 μL quenched samples were analyzed with a
SpectraMax 190 Microplate Reader. A standard curve with Na2S was generated to determine HSconcentration if possible.
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CHAPTER 3: RESULTS
H100 of SclA aligns to D146 of hSCL
It is already known that the selenocysteine specificity of hSCL is strongly governed by one
active site residue: D146 [50, 51]. With this in mind, we wondered if this “single-residue” property
held true in a previously characterized bacterial SCL: SclA. To search for putative specificitydetermining residues in SclA, we generated a multiple sequence alignment with various
characterized NifS-like proteins using Clustal Omega (Figure 1). According to the alignment,
H100 appeared to directly align with D146, implying that H100 may likewise function as a
determinant for selenium-over-sulfur discrimination. Furthermore, various conserved regions were
shared throughout the protein sequences including the catalytic cysteines, PLP-binding lysines,
and group I and II bacterial NifS-like consensus sequences. In the case of SclA, the presence of
the RXGXHCA consensus sequence in the active site confirms its identity as a group II bacterial
NifS-like protein [32, 34]. These aligned regions further added confidence to the hypothesis that
H100 may function similarly to D146.
After the initial sequence alignment, we were interested in comparing the structural
positions of D146 and H100—while the former is a verified catalytic residue in the active site, the
location of the latter is unknown. To further investigate the potential role of H100 as a specificitydetermining residue and probe the structural question, we generated three-dimensional models of
SclA and hSCL using PyMOL. While hSCL could easily be modeled due to already possessing a
known crystal structure, there was greater difficulty in modeling SclA since it lacked one; thus,
we used SWISS-MODEL to search for closely related structural homologs of SclA. The top result
was SufS from B. subtilis which shared 36.99% sequence identity with the E. faecalis enzyme;
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furthermore, a crystal structure of SufS had been determined in a previous study [66]. With
SWISS-MODEL, we threaded the primary sequence of SclA through SufS, generated a putative
3-D structure, and further modeled it using PyMOL. The results of both homology models are
shown in Figure 2. Fortunately, the model of WT hSCL highly resembled its crystal structure,
containing the conserved NifS-like residues—the PLP-bound K259 and catalytic C388—in its
active site (Figure 2A). Another conserved residue, H145, was located nearby the PLP molecule
and C388, implying a role in catalysis. Finally, D146 was found within 4 angstroms of C388, as
predicted by the crystal structure [50]. Additionally, Figure 2B shows the predicted active site of
hSCL with a D146K mutation, visualizing the difference in charge. In Figure 2C, the predicted
active site of WT SclA contained the following conserved NifS-like residues: K202 and C341.
Because this structure is purely hypothetical, PLP could not be modeled bound to K202 like it was
bound to K259 of hSCL, having already been present in the crystal structure. The residue that
aligns to H145 from hSCL in SclA, H99, appeared to likewise position itself next to C341.
Furthermore, H100 also seemed to occupy a position away from the cluster of residues similar to
D146 of hSCL. The configuration of these residues in SclA (Figure 2C) seems to spatially mimic
the configuration in hSCL (Figure 2A). While the bacterial model is strictly putative, these data
seem to imply that the active sites of both enzymes are highly comparable.
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Figure 1: Sequence alignment of SclA and other NifS-like proteins
NifS-like protein sequences from several organisms were aligned using Clustal Omega [55].
Smaller segments of the alignment were selected to highlight relevant residues. The arrow
indicates the alignment of D146 of human SCL (green) to H100 of E. faecalis SclA (blue). The
core catalytic cysteine residue is highlighted in red while the PLP-binding lysine residue is
highlighted in purple. The consensus sequences for group I (SSGSACTS) and group II
(RXGXHCA) bacterial NifS-like proteins are shaded in gray [32, 34]. Fully conserved residues
are indicated by asterisks (*). Partially conserved residues are indicated by colons (:) for residues
with strong similarity and periods (.) for residues with weak similarity.
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Figure 2: The modeled structure of SclA is similar to the defined hSCL active site
3-D structures of human SCL and SclA were modeled using PyMOL [56]. The primary sequence
of SclA was threaded through the established crystal structure of B. subtilis SufS as a template to
create a homology model using SWISS-MODEL [57]. (A) Active site of WT human SCL as
determined by X-ray crystallography [50]. (B) Active site of human SCL with a D146K mutation.
(C) Putative active site of WT SclA, (D) SclA H100K, (E) SclA H100D, (F) SclA H100A, and
(G) SclA H100N, based on homology modeling with SufS using PyMOL.
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H100 point mutants of SclA were successfully generated
Since a D146K mutation in hSCL resulted in the appearance of CDS activity, we
hypothesized that a mutation of H100 would influence SclA in a similar manner. To begin probing
this question, H100 was mutated to several amino acid residues of differing character (H100K,
H100D, H100A, and H100N) via ‘Round-the-horn site-directed mutagenesis; these mutations
were selected to ascertain the substrate specificity and catalytic influence of basic, acidic,
nonpolar, and polar uncharged properties, respectively. An ethidium bromide agarose gel
showcasing the individual ~6.9 kb PCR products after mutagenesis is shown in Figure 3A, clearly
demonstrating successful PCRs and product purity. These PCR products were gel-extracted,
ligated, and transformed into E. coli strain NEB 5-α which was then utilized for plasmid minipreps.
To confirm the presence of each mutation, the mutant plasmid minipreps were sequenced (Figure
3B). The sequencing chromatograms for WT and all mutants revealed well-defined signal peaks
with minimal background noise and clear distinction between the base calls, indicating the purity
of the sequencing reactions and successful mutagenesis of H100.
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Figure 3: Site-directed mutagenesis of SclA
The plasmid containing sclA (EF2568), pRT1, was subjected to ‘Round-the-horn site-directed
mutagenesis in order to generate several H100 point mutants [58, 59]. Primers for each PCR are
listed in Table 1. (A) Ethidium bromide agarose gel displaying PCR products of each mutagenesis.
(B) Sequencing chromatograms of regions of interest from each sequenced plasmid. Target codons
are underlined. Signal peaks indicate sequenced bases and sample purity. Chromatograms were
generated from sequencing results by GENEWIZ and displayed using SnapGene Viewer (GSL
Biotech).
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SclA H100 mutants can be overexpressed and purified
Before beginning to answer the substrate specificity question regarding H100, pure soluble
forms of each mutant enzyme needed to be obtained. To achieve this goal, mutant plasmids were
transformed into E. coli strain Lemo21(DE3). All proteins were overexpressed and purified in the
same manner as described in Materials and Methods. Thus, Figures 4A, 4B, and 4C were included
to showcase only the H100K purification as an example and avoid redundancy. In Figure 4A, a
relatively sizable ~42 kDa band corresponding to the theoretical weight of SclA appeared after
induction with IPTG, indicating that SclA can be overexpressed heterologously; moreover,
successful induction of the target protein further confirmed the results of the earlier transformation.
Additionally, the protein seemed to present mostly within the insoluble fraction even after a 7hour induction at 25 °C with 0.5 mM IPTG. Nevertheless, the amount of target protein in the
soluble lysate was sufficient for purification and downstream experiments. Initially, cobalt affinity
chromatography was used to capture SclA from the lysate, successfully eliminating most of the E.
coli contaminants with 5 mM imidazole in the batch-binding step and 20 mM imidazole in
subsequent washes (Figure 4B). Contaminants with molecular weights lower than ~40 kDa coeluted with the target protein—the banding pattern implies either proteolytic degradation or Nterminal truncation since all mutants were N-terminally His6-tagged. Finally, anion exchange
chromatography was used as a polishing step to rid the target protein of any lingering contaminants
that were not removed with moderate amounts of imidazole (Figure 4C). After purification was
completed, elutions were pooled together, dialyzed, and inspected on an SDS-PAGE gel (Figure
4D). All results described for purification of this mutant were comparable for all other
purifications; all mutants in Figure 4D were determined to be pure for downstream
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experimentation. Overall, these results demonstrate that SclA and selected point mutants can be
overexpressed and purified to homogeneity for future studies; additionally, because the H100
mutants could be purified from the soluble lysates, it stands to reason that H100 does not seem to
play a significant role in protein folding.
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Figure 4: Purification scheme and purity of SclA and mutant proteins
SclA and several mutants were overexpressed in E. coli and purified with cobalt affinity and anion
exchange column chromatography. The results are shown here via Coomassie-stained SDS-PAGE
gels. For further details, see Materials and Methods. As an example of the purification scheme,
gels from the H100K purification are shown in panels A-C. (A) Gel tracking protein induction,
cell lysis, and pooled elutions from each chromatographic step. Co++ and Q elutions were pooled
from their respective steps in panels B and C. (B) Gel demonstrating the cobalt affinity
chromatographic step. (C) Gel demonstrating the subsequent anion exchange chromatographic
step. (D) Gel showcasing the relative purity of all pooled enzymes after their respective
purifications. Wells were loaded with 2.5 μg of dialyzed protein.
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SclA H100 mutants demonstrate varying Michaelis-Menten kinetics for L-selenocysteine
To ascertain the effects of H100 mutations on substrate specificity, purified proteins were
assayed for SCL activity using the lead acetate assay. Because other NifS-like enzymes report the
formation of a persulfide linkage between the sulfur atom and the catalytic cysteine, a similar
mechanism may be happening in SCLs [49]. In SCLs, HSe- may not be the “true” product of the
reaction; rather, the selenium atom may be linked to the catalytic cysteine through a selenosulfide
bond similar to CDSs. In order to break this bond and release the selenium, a strong reductant like
DTT must be used. Moreover, HSe- can only be detected spectrophotometrically if reduced to
H2Se and complexed with lead, forming PbSe which is observable at 400 nm; thus, the catalytic
activity of SclA can be analyzed with the lead acetate assay in order to determine the kinetics of
its SCL activity. Figures 5 through 9 reveal the SCL activities of WT SclA and its H100 point
mutants.
A thorough investigation of each enzyme revealed that they all exhibited Michaelis-Menten
kinetics for L-selenocysteine at varying levels relative to each other. The kinetic parameters of
each mutant (including standard deviations) are catalogued in Table 2. WT SclA exhibited a Kmapp
of 3.55 ± 0.32 mM for L-selenocysteine (Figure 5) with H100K and H100N indicating similar
values of 3.71 ± 0.17 mM (Figure 6) and 3.38 ± 0.26 mM (Figure 9), respectively. Curiously,
H100D displayed the weakest affinity for L-selenocysteine, showcasing a Kmapp of 5.02 ± 0.49 mM
(Figure 7); conversely, H100A demonstrated the strongest affinity for L-selenocysteine with a
Kmapp of 1.86 ± 0.13 mM (Figure 8). Furthermore, H100K and H100N exhibited the highest Vmaxapp
values of 8.34 ± 0.13 μmol min-1 mg-1 and 9.89 ± 0.25 μmol min-1 mg-1 while WT, H100D, and
H100A had lower values that were all relatively similar. Though H100K and H100N exhibited the
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highest significant turnover numbers (kcat) of 5.79 ± 0.09 s-1 and 6.86 ± 0.17 s-1 respectively, the
most catalytically efficient (kcat/Kmapp) enzymes were H100A with a value of 2.44 s-1 mM-1 and
H100N with the value of 2.03 s-1 mM-1 (Table 2). While H100N exhibited faster turnover, the
higher binding affinity for L-selenocysteine in H100A heavily contributed to its catalytic
efficiency. However, all significant kinetic differences regarding Kmapp, Vmaxapp, kcat, and kcat/Kmapp
due to H100 mutations only resulted in <2-fold changes compared to WT.
It is worth noting that some enzymes displayed substrate inhibition at concentrations above
10 mM L-selenocysteine. The enzymes that experienced substrate inhibition were WT, H100D,
and H100A. Because this non-Michaelis-Menten phenomenon skewed the Michaelis-Menten
parameters of the data sets, these inhibitory concentrations were omitted from their respective
figures. Altogether, the kinetic variance in each mutant confirms that H100 is in the active site of
the enzyme and may be playing a role in catalysis.
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Figure 5: SclA exhibits Michaelis-Menten kinetics with L-selenocysteine as a substrate
The selenocysteine lyase kinetics of purified WT SclA were determined using the lead acetate
assay. The saturation curve was generated by fitting initial rates (V0) to the Michaelis-Menten
equation using GraphPad Prism 8. Kinetic parameters provided below the curve are described
further in Table 2. Vmaxapp is indicated by a dotted asymptote drawn on the y-axis. Data points
above 10 mM L-selenocysteine were excluded due to apparent substrate inhibition.
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Figure 6: H100K exhibits faster turnover with similar affinity for L-selenocysteine
The selenocysteine lyase kinetics of purified SclA H100K were determined using the lead acetate
assay. The saturation curve was generated by fitting initial rates (V0) to the Michaelis-Menten
equation using GraphPad Prism 8. Kinetic parameters provided below the curve are described
further in Table 2. Vmaxapp is indicated by a dotted asymptote drawn on the y-axis.
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Figure 7: H100D exhibits the weakest affinity for L-selenocysteine
The selenocysteine lyase kinetics of purified SclA H100D were determined using the lead acetate
assay. The saturation curve was generated by fitting initial rates (V0) to the Michaelis-Menten
equation using GraphPad Prism 8. Kinetic parameters provided below the curve are described
further in Table 2. Vmaxapp is indicated by a dotted asymptote drawn on the y-axis. Data points
above 10 mM L-selenocysteine were excluded due to apparent substrate inhibition.
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Figure 8: H100A exhibits the strongest affinity for L-selenocysteine
The selenocysteine lyase kinetics of purified SclA H100A were determined using the lead acetate
assay. The saturation curve was generated by fitting initial rates (V0) to the Michaelis-Menten
equation using GraphPad Prism 8. Kinetic parameters provided below the curve are described
further in Table 2. Vmaxapp is indicated by a dotted asymptote drawn on the y-axis. Data points
above 15 mM L-selenocysteine were excluded due to apparent substrate inhibition.
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Figure 9: H100N exhibits the fastest turnover for L-selenocysteine
The selenocysteine lyase kinetics of purified SclA H100N were determined using the lead acetate
assay. The saturation curve was generated by fitting initial rates (V0) to the Michaelis-Menten
equation using GraphPad Prism 8. Kinetic parameters provided below the curve are described
further in Table 2. Vmaxapp is indicated by a dotted asymptote drawn on the y-axis.
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L-Cysteine inhibits the SCL activities of H100 mutants
It is known that L-cysteine acts as an SCL inhibitor [37-39]. To determine the effect of Lcysteine on the SCL activity of the bacterial enzyme, the lead acetate assay was repeated with
several concentrations of L-cysteine for WT and all mutants. Because the assay is costly to run,
only four concentrations of L-selenocysteine and L-cysteine were chosen; two concentrations of
substrate above and below the Kmapp values of each enzyme were selected while L-cysteine
concentrations of 0.25 mM, 0.5 mM, 0.75 mM, and 1 mM were decided upon. Double-reciprocal
plots were generated from the initial rates of HSe- formation to determine the type of inhibition
mediated by L-cysteine (Figures 10-14). Upon visible inspection of the double-reciprocal plot for
WT, L-cysteine seems to act as a competitive inhibitor due to the fact that the trendlines appear to
roughly converge on a single point above the x-axis while the slopes change with each varying
condition, resulting in varying x-intercepts (Figure 10). Thus, the Vmaxapp does not appear to change
while the Kmapp changes significantly upon L-cysteine titration, indicating competitive inhibition.
While this effect differs slightly with each mutant, the overall trend appears to be the same.
To determine the Kiapp values of each mutant, the same rates were fit with a competitive
inhibition model in GraphPad Prism 8—the values and calculated error (standard deviation) are
listed in Table 2. WT exhibited a Kiapp of 0.55 ± 0.09 mM for L-cysteine (Figure 10) while H100D
and H100N exhibited similar values of 0.62 ± 0.07 mM (Figure 12) and 0.57 ± mM (Figure 14).
Curiously enough, H100K demonstrated the weakest affinity for inhibitor with a Kiapp of 1.24 ±
0.15 mM which accounted for a ~2.3-fold increase compared to WT (Figure 11). On the other
hand, H100A demonstrated the strongest affinity with a value of 0.39 ± 0.05 mM (Figure 13).
Accounting for standard deviation, the Kiapp for H100A was only slightly different from WT (~1.4-
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fold decrease in Kiapp), so the actual significance of this value may be unclear. Strangely, all Kiapp
parameters were well below all reported Kmapp values in this study, implying that L-cysteine binds
substantially better to the enzyme compared to its primary substrate, L-selenocysteine. Overall,
the variance in competitive inhibitory data further supports the notion that H100 influences
catalysis and that mutagenesis of this residue perturbs the active site in a subtle manner.
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Figure 10: SclA’s selenocysteine lyase activity is inhibited by L-cysteine in a competitive
manner
The selenocysteine lyase activities of purified WT SclA in the presence of increasing
concentrations of L-cysteine were determined by the lead acetate assay. Four concentrations of Lselenocysteine (two above and below the Kmapp) were utilized. Double-reciprocal plots were
generated from initial rates (V0) using the Lineweaver-Burk model in GraphPad Prism 8. Kiapp and
standard deviation values were calculated by fitting initial rates to the competitive inhibition model
in the same program. Error bars indicate standard deviation; error bars smaller than the data points
are not shown.
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Figure 11: H100K exhibits the weakest affinity for L-cysteine as an inhibitor
The selenocysteine lyase activities of purified SclA H100K in the presence of increasing
concentrations of L-cysteine were determined by the lead acetate assay. Four concentrations of Lselenocysteine (two above and below the Kmapp) were utilized. Double-reciprocal plots were
generated from initial rates (V0) using the Lineweaver-Burk model in GraphPad Prism 8. Kiapp and
standard deviation values were calculated by fitting initial rates to the competitive inhibition model
in the same program. Error bars indicate standard deviation; error bars smaller than the data points
are not shown.
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Figure 12: H100D exhibits no significant change in inhibition by L-cysteine
The selenocysteine lyase activities of purified SclA H100D in the presence of increasing
concentrations of L-cysteine were determined by the lead acetate assay. Four concentrations of Lselenocysteine (two above and below the Kmapp) were utilized. Double-reciprocal plots were
generated from initial rates (V0) using the Lineweaver-Burk model in GraphPad Prism 8. Kiapp and
standard deviation values were calculated by fitting initial rates to the competitive inhibition model
in the same program. Error bars indicate standard deviation; error bars smaller than the data points
are not shown.
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Figure 13: H100A exhibits the highest affinity for L-cysteine as an inhibitor
The selenocysteine lyase activities of purified SclA H100A in the presence of increasing
concentrations of L-cysteine were determined by the lead acetate assay. Four concentrations of Lselenocysteine (two above and below the Kmapp) were utilized. Double-reciprocal plots were
generated from initial rates (V0) using the Lineweaver-Burk model in GraphPad Prism 8. Kiapp and
standard deviation values were calculated by fitting initial rates to the competitive inhibition model
in the same program. Error bars indicate standard deviation; error bars smaller than the data points
are not shown.
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Figure 14: H100N exhibits no significant change in inhibition by L-cysteine
The selenocysteine lyase activities of purified SclA H100N in the presence of increasing
concentrations of L-cysteine were determined by the lead acetate assay. Four concentrations of Lselenocysteine (two above and below the Kmapp) were utilized. Double-reciprocal plots were
generated from initial rates (V0) using the Lineweaver-Burk model in GraphPad Prism 8. Kiapp and
standard deviation values were calculated by fitting initial rates to the competitive inhibition model
in the same program. Error bars indicate standard deviation; error bars smaller than the data points
are not shown.
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SclA demonstrates weak CDS activity
Because L-cysteine, an inhibitor, bound to SclA and its mutants with higher affinity than
its primary substrate, L-selenocysteine, we began to ponder whether SclA might act on L-cysteine
if substantial amounts of protein were used in the assay. The methylene blue assay was used to
determine if SclA could generate HS- from L-cysteine. Briefly, if HS- is generated by a NifS-like
protein, it is reduced to H2S by a strong reductant and then, upon the addition of DPD and FeCl3,
converted to methylene blue which is detectable at 650 nm. Using the same amount of enzyme (15
μg/mL, 0.36 μM) as the lead acetate assay and 1 mM L-cysteine, we observed no significant
absorbance change over time (Figure 15A). While it seemed like H100K, H100A, and H100N
were slowly evolving more HS- than WT and H100D, the signal-to-noise ratios were so miniscule
that they could have been mistaken for background noise. To verify if the absorbance changes
were due to weak signals, 100 μg/mL (2.4 μM) of enzyme were added to probe whether very small
amounts of product might be detected. Repeating the assay with this amount of enzyme revealed
that all mutants including the WT generated a significant amount of HS- within the observed
timeframe, implying that SclA already possesses extremely poor CDS activity (Figure 15B).
Because this activity was so weak compared to SCL activity, HS- concentrations could not be
derived from sample absorbances because they were well below the linear range of the Na2S
standard curve. While all reactions were determined at 1 mM L-cysteine, HS- rates seemed to differ
amongst all mutants, implying that H100 may also play a role in CDS activity.

45

Figure 15: SclA and mutants demonstrate poor cysteine desulfurase activity
The CDS activities of purified SclA and H100 mutants were determined by the methylene blue
assay with 1 mM L-cysteine. Data points were fit with a linear regression using GraphPad Prism
8. Error bars indicate standard deviation; error bars smaller than the data points are not shown. (A)
Reaction progress curve of sulfide production with 15 μg/mL (0.36 μM) enzyme. (B) Reaction
progress curve of sulfide production with 100 μg/mL (2.4 μM) enzyme.
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CHAPTER 4: DISCUSSION
Manipulation of the catalytic cysteine may provide specificity
In this work, we further characterized the substrate specificity of SclA by investigating its
enzyme kinetics after mutation of a putative active site residue: H100. Without a crystal structure,
it is difficult to draw conclusions concerning the catalytic residues in the active site of SclA, but
the alignment and homology models shown earlier can function as guides for analysis. It is also
important to note that the pKa of the catalytic cysteine, C341, is yet unknown. In water-based
solutions, free cysteine has a pKa of ~8.5, resulting in mostly protonated and unreactive thiol groups
at physiological pH. However, this is not always the case within the active site of a protein where
catalytic cysteine residues are comparatively more reactive due to acidic pKa values. The active
site microenvironment of a protein contains clusters of differently-charged amino acid residues
that greatly influence the pKa values of catalytic cysteines—in this case, a lowering of the pKa
results in deprotonation to the reactive thiolate species at physiological pH. As stated earlier, CDSs
contain a conserved reactive thiolate which non-specifically attacks sulfur or selenium, depending
on the substrate [49]. On the other hand, SCLs are implied to contain a thiol group rather than a
thiolate, thereby limiting its reactivity to only L-selenocysteine rather than L-cysteine. It has been
hypothesized that L-selenocysteine likely deprotonates the thiol to a thiolate which could then
attack the electrophilic substrate—as stated earlier, L-cysteine does not exhibit this type of
biochemical reactivity at physiological pH [51]. In hSCL, D146 may have destabilized this thiolate
group, restricting it to the protonated species [50, 51]. Thus, it would stand to reason that the
specificity of SCLs most likely lies within controlling the protonation state of the catalytic cysteine
via nearby residues. Perhaps this may also occur in SclA.
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H100 may not function as a catalytic residue
In SclA, the function of H100 is still unclear. The significant changes in HSe- kinetics from
each mutant implied that it played a role in catalysis; the positively-charged imidazolium group of
histidine would probably act as a general base to abstract the hydrogen atom from C341’s thiol
group. However, while the changes in kinetics amongst enzymes were significant, the differences
in turnover and catalytic efficiency were only slight (<2.0-fold differences in both kcat and
kcat/Kmapp). Therefore, H100 may not act as a base for catalysis; it may just only influence the pKa
of the thiol in a minor fashion. Additionally, because selenocysteine is a potent nucleophile, it
most likely abstracts the thiol’s proton in the first place, rendering any other base catalysis
unnecessary and allowing specificity over cysteine—this may also explain why the H100 mutants
were still able to react with L-selenocysteine.

SclA binds L-cysteine better than L-selenocysteine
The inhibition of SCLs by L-cysteine is a puzzling phenomenon. Enzymes inhibited by a
common metabolite constantly present in high amounts would be extremely inefficient. In SclA,
the Kiapp for L-cysteine was determined to be 0.55 ± 0.09 mM while the Kmapp for L-selenocysteine
was 3.55 ± 0.32 mM. In hSCL, the Kiapp is 5.85 mM while the Kmapp for L-selenocysteine is 0.50
mM [39]. In contrast to hSCL, SclA seems to have a greater affinity for L-cysteine than Lselenocysteine (~6.5-fold difference between Kmapp and Kiapp), even though it turns over Lselenocysteine better than L-cysteine. The difference in binding affinities may suggest an overall
distinction between the two enzymes—indeed, comparing prokaryotic and eukaryotic enzymes is
difficult and may allow for misinterpretation of data without the aid of a crystal structure (in the
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case of SclA). In terms of kinetic changes, H100K exhibited the weakest affinity for L-cysteine as
an inhibitor (~2.3-fold increase in Kiapp). The lysyl residue may have changed the pH of the active
site in a way that slightly disfavors binding of L-cysteine. Contrastingly, H100A had the highest
binding affinity to L-cysteine, but it is unclear whether or not its Kiapp is significant enough to make
that claim (~1.4-fold decrease). It is important to note that the inhibition studies in this work were
carried out using only four concentrations of substrate, and this may have produced results that are
probably not indicative of the “true” inhibitor constants for each enzyme. For a full investigation
into the L-cysteine inhibition, more data points would be sufficient. Overall, H100 mutagenesis
did not seem to affect binding of L-cysteine as much as it did L-selenocysteine catalysis which
may reveal something about the pKa of C341’s sulfhydryl group.

H100 does not solely confer specificity for L-selenocysteine
Because D146K in hSCL resulted in loss of specificity, we believed a similar charge
inversion in H100D would generate a similar result. Unexpectedly, the HS- activity of H100D did
not seem to differ significantly from the rest of the mutants, implying that the pKa of C341 may
not have been lowered enough to display non-specificity—this could be due to another unknown
residue nearby. Furthermore, the mutants were only able to generate HS- when there was a
substantial amount of enzyme in the assay—the flaw with this method lies in the fact that the
protein samples are not completely pure. It is not possible to obtain 100% pure protein from a
preparation; moreover, the sensitivity of Coomassie stains is not high enough to detect all the
contaminants in a protein prep unless the gel is overloaded. While Figure 4D shows pure enzymes
at 2.5 μg, another gel was run with 5.0 μg of enzymes to check for contaminants (data not shown).
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Faint contaminating bands appeared in all lanes, and this may be problematic if the methylene blue
assay is overloaded with 100 μg/mL of enzyme. Therefore, it is probable that the CDS activity in
Figure 15B may be due to contributions of “hidden” CDS activities from contaminants from each
prep. Nevertheless, the mere appearance of CDS activity may still be significant. Depending on
how the data is analyzed, there are two interpretations: 1) the appearance of weak CDS activity is
novel and suggests that SCLs are not as specific as previously thought, or 2) the CDS activity
generated in this study may be due to an artifact or contaminant from protein purification. Since
the pKa of C341 may be important in determining specificity, it is recommended that future
experiments must be tuned towards “tweaking” the pKa of C341 via pH-activity studies of the
enzyme and mutagenesis of other neighboring residues.

Thiol-based reductants affect the kinetics of NifS-like proteins
Historically, thiol-based reductants like DTT have been used to assay the SCL and CDS
activities of NifS-like enzymes, but this creates an inherent problem when determining the pKa of
the catalytic sulfhydryl: the reductant itself may be reacting with the sulfhydryl, thereby affecting
the kinetics of the enzyme. Because it has been observed that DTT nucleophilically attacks and
displaces the sulfur atom bound to the catalytic thiolate in IscS, it can be assumed that a similar
reaction probably occurs in SclA [33]. In fact, it has been shown in Slr0387, a CDS in
Synechocystis sp. PCC 6803, that the mechanism of persulfide cleavage by DTT is due to the
dithiol forming a complex with PLP in order to position itself for attacking the catalytic sulfhydryl;
moreover, the authors observed that this is the rate-determining step of catalysis, thus confounding
any kinetic studies when DTT is the reductant [67]. Furthermore, the authors made the observation
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that some CDSs including Slr0387 are subject to inhibition by L-cysteine when DTT is the
reductant [67]. They hypothesize that this may be due to both thiol-based molecules competing for
the same catalytic sulfhydryl where, in one scenario, a DTT-PLP complex prevents L-cysteine
from binding, and conversely, L-cysteine prevents DTT from binding to cofactor [67]. Lastly, the
authors found that using tris(2-carboxyethyl)phosphine (TCEP), a nonthiol, as a reductant was
much more efficient in cleaving the persulfide bond compared to DTT (~10-fold increase in kcat)
and did not seem to exhibit a rate-limiting effect [67]. If any future studies on the mechanism of
SclA are to be undertaken, the utilization of a non-thiol reductant (like TCEP) may eliminate any
confounding variables when attempting to determine the pKa of C341.

The inefficiency of SclA may prevent HSe- toxicity in vivo
It is important to note that all Kmapp values were in millimolar amounts, well above the
physiological concentration of L-selenocysteine which is expected to be in low micromolar levels
in the cell. Because HSe- is incredibly toxic, uncontrolled release of this reactive species would
not be favorable for any organism. Therefore, it may make sense that the relatively slow
physiological turnover of this enzyme due to incredibly low substrate affinity serves as an internal
control mechanism to prevent accidental poisoning of the cell. Moreover, the higher affinity for
L-cysteine as evidenced by the Kiapp values implies that the enzyme would almost always bind the
inhibitor rather than its preferred substrate considering the fact that there is most likely ~1000-fold
more L-cysteine than L-selenocysteine in the cytosol. While this undoubtedly decreases the
enzyme’s efficiency for L-selenocysteine degradation even more, one must further consider the
repercussions of releasing free HSe- into the cytosol such as thiol-mediated redox cycling [28, 29].
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Coupled with its weak L-selenocysteine binding affinity, it is possible that the enzyme contains a
sophisticated feedback mechanism to control HSe- production as soon as it disengages the
ribosome by sequestering itself with the large amount of cellular L-cysteine. If the enzyme were
immediately “shut off” by the physiological concentration of L-cysteine to prevent HSe- release,
it may stand to reason that an additional factor may be required for the enzyme to “turn on” again
and carry out its true biological function, whatever it may be.

SclA may channel HSe- to an unknown electron acceptor
While a role for SCLs has not been elucidated, it has been shown that some NifS-like
enzymes can participate in mobilizing HSe- from L-selenocysteine to SPS in vitro [68-70]. The
results of these mobilization studies heavily imply that the chemical species in vivo is most likely
a selenium intermediate bound to the catalytic cysteine of SCLs that is meant to be transferred to
another protein; in other words, SCLs probably do not randomly release HSe- into the cellular
environment. Because E. faecalis contains one known enzyme that requires selenium, it is
hypothesized that SclA may contribute overall to the synthesis of that enzyme. Moreover, because
this enzyme is a selenium-dependent XDH, E. faecalis therefore possesses this uncharacterized
third trait of specific incorporation—thus, the generation of HSe- from L-selenocysteine for SPS
via SclA may be the first step in this pathway. Indeed, the specificity of this enzyme towards Lselenocysteine would be crucial in synthesizing XDH. Since E. coli SPS does not recognize HSand produce SPO3, it may be true that the selD gene product in E. faecalis may also not recognize
the trace amounts of HS- weakly generated by SclA [30]. This assumption would most likely
explain a mechanism to prevent accidental incorporation of a sulfur cofactor in place of selenium,
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and while this has not been observed in vivo, most molybdenum hydroxylases tend to contain labile
sulfur atoms in their active sites [71].
In the same genetic locus as SclA, SelD, and XDH, other genes have been identified as
putatively involved in SDMH biosynthesis such as yqeB and yqeC; past studies have shown that
yqeB and yqeC generally co-localize with selD in many organisms lacking the ability to synthesize
selenoproteins and selenium-containing tRNAs [42, 46]. These two genes may encode products
that function to shuttle selenium in the SDMH biosynthetic pathway. The rationale for this
“selenium-channeling” hypothesis stems from the fact that most CDSs are known to mobilize
sulfur via protein-protein interactions; for example, in A. vinelandii, the Fe-S clusters in
nitrogenase are synthesized by an interaction where NifS presents its thiol-bound sulfur
intermediate to NifU, a scaffolding protein [72]. In another example from both A. vinelandii and
E. coli, IscS carries out a similar reaction with its partner, IscU [73, 74]. The similarities between
the two subclasses of NifS-like proteins cannot be overstated—if CDSs can mobilize sulfur, surely
SCLs can mobilize selenium. Because SCLs have low affinity for L-selenocysteine according to
their millimolar Kmapp constants, it is possible that they may require the presence of other proteins
to vastly increase effective substrate affinity, assuming that they do mobilize selenium. Indeed,
releasing HSe- would be disastrous for the cell, and with the molecule itself being oxygen-labile,
exposure to the cytosol would probably oxidize it to an unusable form. As of yet, SCLs are not
known to have any in vivo electron acceptors, but the gene products of selD, yqeB, and yqeC may
be likely candidates in the case of SclA. An analysis of SclA’s kinetics in the presence of all three
proteins is recommended to probe this question.
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A crystal structure of SclA may be required for future studies
Since the hypothesis of H100 determining specificity was based on a sequence alignment,
future studies may benefit from generating a crystal structure of SclA instead. As stated before, it
is difficult to carry out mechanistic studies without a crystal structure as a guide, and while the
alignments and models offered good estimates of the SclA active site, it still does not show us the
full biochemical picture. Because the models in Figure 2C-2G were generated using B. subtilis
SufS as a homology template, the 3-D spatial arrangement may be entirely skewed. An important
characteristic of hSCL’s specificity is partly due to a mechanical conformational change that is
dependent on substrate-binding. As determined by the hSCL crystal structure, C388 is located on
a dynamic segment that shifts whenever substrate is bound in the active site [50]. The dynamic
segment has been found in both an “open” conformation (with C388 exposed to solvent) and a
“closed” conformation (with C388 sequestered in the active site near the cofactor) [50]. Visualized
in Figure 2A, this closed conformation may prevent accidental release of HSe- into the cytosol
while simultaneously preventing it from becoming oxidized. In SclA, however, it is unknown if a
similar mechanism exists, and this is impossible to visualize with just a putative model because
SufS does not contain this mechanism. Using a non-SCL as a template to model SclA may present
a flawed view of the active site; therefore, a crystal structure may be the best solution to this
problem and will ultimately provide more insight into the residues involved in selenium-oversulfur specificity.

54

APPENDIX: TABLES
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Table 1: Oligonucleotides used for site-directed mutagenesis
Primer name

Nucleotide sequence (5’ → 3’)

H100K FWD

AAAGCAGTAGCTAGACCTCTTCACTTAC

H100D FWD
H100A FWD
H100N FWD

GATGCAGTAGCTAGACCTCTTCACTTAC
GCTGCAGTAGCTAGACCTCTTCAC
AATGCAGTAGCTAGACCTCTTCACTTAC

H100 REV

ATGTTCTAACATAGTCGTAATCACATGGTCG

Nucleotides that are bolded and underlined represent the mutant codons replacing the WT codon
encoding H100.
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Table 2: Kinetic parameters of SclA and selected point mutants
Enzyme

Kmapp
(mM L-Sec)

Vmaxapp
(μmol min-1 mg-1)

kcat
(s-1)

kcat/Kmapp
(s-1 mM-1)

Kiapp
(mM L-Cys)

WT
H100K
H100D
H100A
H100N

3.55 ± 0.32
3.71 ± 0.17
5.02 ± 0.49
1.86 ± 0.13
3.38 ± 0.26

6.38 ± 0.25
8.34 ± 0.13
6.50 ± 0.30
6.53 ± 0.14
9.89 ± 0.25

4.43 ± 0.17
5.79 ± 0.09
4.52 ± 0.21
4.54 ± 0.10
6.86 ± 0.17

1.25
1.56
0.90
2.44
2.03

0.55 ± 0.09
1.24 ± 0.15
0.62 ± 0.07
0.39 ± 0.05
0.57 ± 0.06

Standard deviations were calculated by GraphPad Prism 8 and are presented as “± SD”. Kiapp
constants were determined separately from all other kinetic constants as outlined in Materials and
Methods.
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